Probo Medical Acquires SonoDepot
Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced today the acquisition of SonoDepot, Inc. (“SonoDepot”). Terms of the transaction were
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XProbo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced today the acquisition of SonoDepot, Inc. (“SonoDepot”). Terms of the transaction were
Seigla Medical, Inc., announced conformité européenne (CE) Mark for the company’s LiquID Guide Catheter Extension for use in coronary and peripheral vasculature interventions. Guide catheter extensions are a
ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system. Offering a
Masimo (NASDAQ: MASI) today announced the U.S. introduction of softFlow®, innovative pulmonary care therapy which provides nasal high-flow warmed and humidified respiratory gases to spontaneously breathing patients. The technology,
Qosina announced that its president and CEO Scott Herskovitz has been elected as an at-large board director of the Bio-Process Systems Alliance (BPSA). Board members of the BPSA,
The British Standards Institution (BSI) has issued the first UKCA mark under the country’s new legislation for medical devices. The business standards company has approved the first UK
ReCor Medical has secured Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its Paradise system to treat uncontrolled hypertension. The Paradise Ultrasound Renal Denervation
Medifacturing company PrinterPrezz has secured $16m in Series A funding round led by New York-based D. One Vision Management. The other investors who participated in the funding round
US-based Bluejay Diagnostics has partnered with Japan’s Toray Industries to develop point-of-care test for COVID-19 patients to detect progression of the disease. Under the collaboration, the two companies
GE Healthcare has received 510k clearance from US FDA for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which come with features based on artificial intelligence (AI) that